Shoulder Innovations, Inc. (NYSE:SI – Get Free Report) major shareholder Healthcare Holding B.V. Gilde sold 99,812 shares of the company’s stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $22.77, for a total transaction of $2,272,719.24. Following the completion of the transaction, the insider owned 2,221,640 shares of the company’s stock, valued at approximately $50,586,742.80. The trade was a 4.30% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.
Healthcare Holding B.V. Gilde also recently made the following trade(s):
- On Monday, August 3rd, Healthcare Holding B.V. Gilde sold 10,751 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.71, for a total transaction of $244,155.21.
- On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.73, for a total transaction of $455,372.82.
- On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The shares were sold at an average price of $23.36, for a total transaction of $659,803.20.
Shoulder Innovations Stock Performance
Shares of SI stock opened at $22.36 on Friday. The stock’s 50-day moving average is $19.79 and its two-hundred day moving average is $16.04. The company has a debt-to-equity ratio of 0.11, a quick ratio of 10.04 and a current ratio of 11.81. Shoulder Innovations, Inc. has a 1 year low of $10.92 and a 1 year high of $24.59. The firm has a market cap of $463.85 million and a price-to-earnings ratio of -0.13.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently modified their holdings of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in shares of Shoulder Innovations during the third quarter worth approximately $28,000. Rhumbline Advisers purchased a new position in Shoulder Innovations in the 3rd quarter valued at $54,000. Wells Fargo & Company MN grew its position in Shoulder Innovations by 66.3% in the 4th quarter. Wells Fargo & Company MN now owns 5,250 shares of the company’s stock valued at $75,000 after buying an additional 2,094 shares during the last quarter. Renaissance Technologies LLC acquired a new position in Shoulder Innovations in the 4th quarter valued at $176,000. Finally, Blue Trust Inc. purchased a new position in Shoulder Innovations during the 1st quarter worth $228,000.
Wall Street Analyst Weigh In
A number of equities analysts have recently commented on SI shares. Piper Sandler reaffirmed an “overweight” rating and issued a $19.00 target price (up from $18.00) on shares of Shoulder Innovations in a report on Friday, May 8th. UBS Group assumed coverage on shares of Shoulder Innovations in a research note on Tuesday, July 28th. They set a “buy” rating and a $27.00 price target for the company. Finally, Weiss Ratings raised shares of Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a research report on Monday. Six research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $22.00.
Read Our Latest Stock Analysis on Shoulder Innovations
Shoulder Innovations News Roundup
Here are the key news stories impacting Shoulder Innovations this week:
- Positive Sentiment: Second-quarter revenue rose 56% year over year to $17.18 million, slightly exceeding the $17.1 million consensus estimate. Gross profit increased 60% to $13.4 million, indicating continued demand and improving product economics. Q2 2026 earnings report
- Positive Sentiment: Management raised its full-year 2026 revenue outlook to $67 million-$69 million, broadly in line with the approximately $67.1 million analyst consensus. First-half revenue growth reached 60%, supporting the company’s expansion narrative. Company earnings release
- Positive Sentiment: Institutional interest was favorable overall: 43 investors increased positions in the latest quarter, compared with 13 that reduced holdings. BlackRock, Millennium Management and other firms reported sizable additions.
- Neutral Sentiment: Analyst sentiment remains generally constructive. UBS initiated coverage with a Buy rating and a $27 price target, while the broader consensus is Moderate Buy; however, reported target prices range from $19 to $27, reflecting valuation uncertainty.
- Negative Sentiment: Adjusted diluted EPS was negative $0.49, missing the roughly negative $0.46-$0.47 consensus. The company posted a $10.2 million net loss, an $10.0 million operating loss and used $7.4 million in operating cash, underscoring its ongoing path to profitability and funding risks.
- Negative Sentiment: Major shareholder Gilde Healthcare sold more than 150,000 shares across recent transactions, including approximately $2.3 million of sales on August 4. Although Gilde retains a substantial position, the repeated selling may weigh on investor sentiment. Gilde Healthcare insider sale
Shoulder Innovations Company Profile
Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.
In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.
Featured Articles
- Five stocks we like better than Shoulder Innovations
- Sandisk Just Delivered a Blowout Quarter—Here’s Why the Stock Is Falling
- 4 Oil and Gas ETF Plays as Prices Stay Sky-High
- What Tesla Stands to Lose If It Walks Away From China
- Disney Sets Up for a Magical Year in 2027
Receive News & Ratings for Shoulder Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shoulder Innovations and related companies with MarketBeat.com's FREE daily email newsletter.
